Monitor for future announcements of financial terms, pilot results, or integration milestones — the collaboration is non-binding in its current form and lacks concrete revenue commitments.
Price Chart
Executive Summary
Firefly Neuroscience announced a strategic collaboration with Radial, the operator of the largest U.S. brain medicine clinic network, to integrate Firefly's FDA 510(k)-cleared AI-powered Evoke EEG/ERP platform into Radial's proprietary AI-native operating system (RadialOS). The deal aims to embed objective brain-function data into clinical workflows across Radial's 27 clinics in seven states, potentially expanding Firefly's commercial reach but with no disclosed financial terms or revenue commitments.
Key Facts
- Firefly Neuroscience (AIFF) announced a strategic collaboration with Radial, operator of the largest U.S. brain medicine clinic network (27 clinics, 7 states).
- The collaboration aims to integrate Firefly's FDA 510(k)-cleared Evoke EEG/ERP platform into Radial's proprietary AI-native operating system (RadialOS).
- No financial terms, upfront payments, milestones, or revenue-sharing details were disclosed.
- Radial is backed by General Catalyst and recently acquired the management services organization supporting Mindful Health Solutions (August 2026).
- Firefly's Evoke platform uses AI-powered qEEG and ERP testing to provide objective brain-function data for conditions including depression, dementia, ADHD, and PTSD.
Financial Impact
No financial terms disclosed; potential commercial expansion but no guaranteed revenue.
Risk Factors
- No financial terms disclosed — collaboration may not generate material near-term revenue.
- Integration and adoption timelines are unspecified; clinical workflow changes may face adoption hurdles.
- Radial's network expansion (27 clinics) is modest relative to national healthcare scale; limited near-term revenue impact.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3363887 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | Press Release | $2.01 $0.9196 | ▼ −54.25% | ▼ −52.77% | $0.9400 (−53.23%) |
Sep 17, 2026 5w ago | Press Release | $1.28 $1.10 | ▼ −14.06% | ▼ −15.52% | $0.9400 (−26.56%) |
Jul 1, 2026 16w ago | EFFECT | $1.29 $1.07 | ▲ +17.05% | ▲ +14.87% | $0.9400 (+27.13%) |
Jun 26, 2026 17w ago | 8-K | $1.23 $1.11 | ▲ +9.76% | ▲ +9.48% | $0.9400 (+23.58%) |
Jun 23, 2026 17w ago | S-3/A | $1.19 $1.13 | ▲ +5.04% | ▲ +6.97% | $0.9400 (+21.01%) |
Jun 22, 2026 18w ago | 8-K | $1.31 $1.12 | ▼ −14.50% | ▼ −15.66% | $0.9400 (−28.24%) |
May 12, 2026 23w ago | 8-K | $1.80 $1.61 | ▲ +10.56% | ▲ +9.94% | $0.9400 (+47.78%) |
Apr 22, 2026 26w ago | 8-K | $2.06 $1.68 | ▼ −18.45% | ▼ −23.08% | $0.9400 (−54.37%) |
Mar 26, 2026 30w ago | Press Release | $3.02 $2.29 | ▼ −24.17% | ▼ −34.84% | $0.9400 (−68.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers